Dapagliflozin trials for Chronic kidney disease

All Dapagliflozin trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Dapagliflozin for Chronic kidney disease

• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
  NCT07239570 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
  NCT06942910 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
  NCT06572215 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 1 location
• Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
  NCT06398977 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
  NCT07491042 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years and older · Sex: All (male and female) · 1 location
• Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients
  NCT05944016 · Phase: Phase 3 · Ages: 10 Years to 39 Years · Sex: All (male and female) · 16 locations

Common questions

How many trials study Dapagliflozin for Chronic kidney disease?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.